Dr. Matthew “Oki” O’Connor in Berlin at Undoing Aging 2019

Oki_undoing-aging-1a-o
Play Video

Dr. Matthew “Oki” O’Connor in Berlin at Undoing Aging 2019. There, he debuted the Underdog Project to the public: a novel approach to attack the leading cause of death.

Share on facebook
Share on twitter
Share on reddit
Share on linkedin
Share on whatsapp
Share on email

Underdog News:

Kizoo Portfolio Company Underdog Closes $10M Financing Round

Underdog Pharmaceuticals, a key investment of Michael Greve’s rejuvenation biotech VC Kizoo, has closed a $10 million round of capital. Kizoo led the company’s Series Seed II round, which saw participation from both existing and new investors.

Underdog was recently awarded the Innovation Passport under the United Kingdom’s Innovative Licensing and Access Pathway (ILAP). This will enable faster patient access to its groundbreaking treatment for the prevention of heart attacks and stroke. The company expects to begin clinical trials in 2023.

Read More »

7-Ketocholesterol in disease and aging

Scientists from Underdog Pharmaceuticals, in conjunction with Professor Jay Jerome of Vanderbilt University Medical Center, have published an article in the journal Redox Biology, covering the role of the toxic biomolecule 7-ketocholesterol, especially in the

Read More »

© 2021 Underdog Pharmaceuticals – ALL RIGHTS RESERVED

Site developed by Moonburn.com

© 2021 Underdog Pharmaceuticals – ALL RIGHTS RESERVED

Site developed by Moonburn.com